The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.

Anabolic-androgenic steroid use and psychopathology in athletes. a systematic review / Piacentino, Daria; Kotzalidis, Georgios; DEL CASALE, Antonio; Aromatario, Maria Rosaria; Pomara, Cristoforo; Girardi, Paolo; Sani, Gabriele. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - STAMPA. - 13:1(2015), pp. 101-121. [10.2174/1570159X13666141210222725]

Anabolic-androgenic steroid use and psychopathology in athletes. a systematic review

PIACENTINO, DARIA;KOTZALIDIS, GEORGIOS;DEL CASALE, ANTONIO;Aromatario, Maria Rosaria;GIRARDI, Paolo;SANI, Gabriele
2015

Abstract

The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.
anabolic-androgenic steroids; doping; mood disorders; psychopathology; psychosis
01 Pubblicazione su rivista::01a Articolo in rivista
Anabolic-androgenic steroid use and psychopathology in athletes. a systematic review / Piacentino, Daria; Kotzalidis, Georgios; DEL CASALE, Antonio; Aromatario, Maria Rosaria; Pomara, Cristoforo; Girardi, Paolo; Sani, Gabriele. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - STAMPA. - 13:1(2015), pp. 101-121. [10.2174/1570159X13666141210222725]
File allegati a questo prodotto
File Dimensione Formato  
Piacentino_Anabolic-androgenic-steroid_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 802.88 kB
Formato Adobe PDF
802.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/788264
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 103
  • ???jsp.display-item.citation.isi??? 94
social impact